The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells
Purpose : The radioprotective effect of the Bowman-Birk protease inhibitor (BBI) was previously shown to result from a TP53 dependent mechanism. Whether this effect involves specific DNA repair mechansims is now tested. Material and methods : Normal human fibroblasts were pre-treated with BBI before...
Gespeichert in:
Veröffentlicht in: | International journal of radiation biology 2000, Vol.76 (2), p.223-229 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 229 |
---|---|
container_issue | 2 |
container_start_page | 223 |
container_title | International journal of radiation biology |
container_volume | 76 |
creator | DITTMANN, K. H DIKOMEY, E MAYER, C RODEMANN, H. P |
description | Purpose : The radioprotective effect of the Bowman-Birk protease inhibitor (BBI) was previously shown to result from a TP53 dependent mechanism. Whether this effect involves specific DNA repair mechansims is now tested. Material and methods : Normal human fibroblasts were pre-treated with BBI before exposure to X-rays, UVB or to chemical agents (bleomycin, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cisplatin). These agents were chosen because of their ability to induce different spectra of DNA damage. The radiometric agent bleomycin primarily induces double-strand breaks (dsb), which are repaired by recombination; MNNG results in alkylated bases which are repaired by base excision repair (BER); cisplatin results in DNA-crosslinks which are repaired mainly by nucleotide excision repair (NER); and finally UVB generates thymine dimers and thymine-cytosine-6-4 products which are also repaired by NER. Cell survival was analysed by colony formation assay and DNA dsb by constant field gel electrophoresis. The combined effect of BBI and X-rays was also tested for XP-fibroblasts, which are defective in NER. Results : For normal human fibroblasts the radioprotective effect of BBI was clearly found by using a delayed plating procedure. The radioprotective effect was found to be unrelated to an altered induction or repair of radiation-induced DNA dsb. Pre-treatment with BBI did not affect cell killing after exposure to bleomycin or MNNG, but resulted in a significant protection of cells exposed to cisplatin or UVB. These results indicate that pre-treatment with BBI did not alter recombination repair or BER, but was able to modify NER. The latter finding was supported by the observation made for XP-cells, where pre-treatment with BBI failed to result in radioprotection after exposure to ionizing radiation. Conclusions : On the basis of these data it is proposed that the radioprotective effect of BBI is the result of an improved nucleotide excision repair mechanism. |
doi_str_mv | 10.1080/095530000138871 |
format | Article |
fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_095530000138871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70972681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-8e4db917b985cab3f8963ed976f2f63a4535b6af6aae33805f257db9970f0ea43</originalsourceid><addsrcrecordid>eNp1kUtv1TAQhS0EoreFNTvkBWIXasd5OOxoBQWpEpuyjibO-MbFsS-20we_ix-IL7mIh1Rv_JjvHI3nEPKCszecSXbKuroWLC8upGz5I7LhoikLkd8fk82-ms-sPCLHMV5nrGRCPiVHnLW8aSqxIT-uJqRn_nYGV5yZ8JXugk8IEalxkxlM8oGim8ApjFRZ7_wWnVFUobU0LuHG3IClXlPjnflu3JYGGA2kfC1SQEg4Urcoiz6ZESneKRNzjQbcgQmF8vMOE7r0yzDSYUnU-bQ3vMPgRwwz0J3ZzhnxcZlX7Bl5osFGfH7YT8iXD--vzj8Wl58vPp2_uyxUVYpUSKzGoePt0MlawSC07BqBY9c2utSNgKoW9dCAbgBQCMlqXdZtVnQt0wyhEifk9eqbh_JtwZj62cR9B-DQL7FvWdeWjeQZPF1BFXyMAXW_C2aGcN9z1u-D6v8LKiteHqyXYcbxL35NJgOvDgBEBVaHHIGJf7hSZiuWsbcrZpz2eVi3PtixT3BvffitEQ830f0jnhBsmhQE7K_9Elye7YMf-AkQ6MRS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70972681</pqid></control><display><type>article</type><title>The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells</title><source>Taylor & Francis</source><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><creator>DITTMANN, K. H ; DIKOMEY, E ; MAYER, C ; RODEMANN, H. P</creator><creatorcontrib>DITTMANN, K. H ; DIKOMEY, E ; MAYER, C ; RODEMANN, H. P</creatorcontrib><description>Purpose : The radioprotective effect of the Bowman-Birk protease inhibitor (BBI) was previously shown to result from a TP53 dependent mechanism. Whether this effect involves specific DNA repair mechansims is now tested. Material and methods : Normal human fibroblasts were pre-treated with BBI before exposure to X-rays, UVB or to chemical agents (bleomycin, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cisplatin). These agents were chosen because of their ability to induce different spectra of DNA damage. The radiometric agent bleomycin primarily induces double-strand breaks (dsb), which are repaired by recombination; MNNG results in alkylated bases which are repaired by base excision repair (BER); cisplatin results in DNA-crosslinks which are repaired mainly by nucleotide excision repair (NER); and finally UVB generates thymine dimers and thymine-cytosine-6-4 products which are also repaired by NER. Cell survival was analysed by colony formation assay and DNA dsb by constant field gel electrophoresis. The combined effect of BBI and X-rays was also tested for XP-fibroblasts, which are defective in NER. Results : For normal human fibroblasts the radioprotective effect of BBI was clearly found by using a delayed plating procedure. The radioprotective effect was found to be unrelated to an altered induction or repair of radiation-induced DNA dsb. Pre-treatment with BBI did not affect cell killing after exposure to bleomycin or MNNG, but resulted in a significant protection of cells exposed to cisplatin or UVB. These results indicate that pre-treatment with BBI did not alter recombination repair or BER, but was able to modify NER. The latter finding was supported by the observation made for XP-cells, where pre-treatment with BBI failed to result in radioprotection after exposure to ionizing radiation. Conclusions : On the basis of these data it is proposed that the radioprotective effect of BBI is the result of an improved nucleotide excision repair mechanism.</description><identifier>ISSN: 0955-3002</identifier><identifier>EISSN: 1362-3095</identifier><identifier>DOI: 10.1080/095530000138871</identifier><identifier>PMID: 10716643</identifier><language>eng</language><publisher>London: Informa UK Ltd</publisher><subject>Biological and medical sciences ; Bleomycin - pharmacology ; Cell Survival - drug effects ; Cell Survival - radiation effects ; Cells, Cultured ; Cisplatin - pharmacology ; DNA Repair - drug effects ; Fundamental and applied biological sciences. Psychology ; Humans ; Methylnitronitrosoguanidine - pharmacology ; Molecular and cellular biology ; Molecular genetics ; Mutagenesis. Repair ; Protease Inhibitors - pharmacology ; Radiation-Protective Agents - pharmacology ; Space life sciences ; Ultraviolet Rays ; X-Rays ; Xeroderma Pigmentosum - genetics</subject><ispartof>International journal of radiation biology, 2000, Vol.76 (2), p.223-229</ispartof><rights>2000 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-8e4db917b985cab3f8963ed976f2f63a4535b6af6aae33805f257db9970f0ea43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/095530000138871$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/095530000138871$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4010,27900,27901,27902,59620,59726,60409,60515,61194,61229,61375,61410</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1280130$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10716643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DITTMANN, K. H</creatorcontrib><creatorcontrib>DIKOMEY, E</creatorcontrib><creatorcontrib>MAYER, C</creatorcontrib><creatorcontrib>RODEMANN, H. P</creatorcontrib><title>The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells</title><title>International journal of radiation biology</title><addtitle>Int J Radiat Biol</addtitle><description>Purpose : The radioprotective effect of the Bowman-Birk protease inhibitor (BBI) was previously shown to result from a TP53 dependent mechanism. Whether this effect involves specific DNA repair mechansims is now tested. Material and methods : Normal human fibroblasts were pre-treated with BBI before exposure to X-rays, UVB or to chemical agents (bleomycin, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cisplatin). These agents were chosen because of their ability to induce different spectra of DNA damage. The radiometric agent bleomycin primarily induces double-strand breaks (dsb), which are repaired by recombination; MNNG results in alkylated bases which are repaired by base excision repair (BER); cisplatin results in DNA-crosslinks which are repaired mainly by nucleotide excision repair (NER); and finally UVB generates thymine dimers and thymine-cytosine-6-4 products which are also repaired by NER. Cell survival was analysed by colony formation assay and DNA dsb by constant field gel electrophoresis. The combined effect of BBI and X-rays was also tested for XP-fibroblasts, which are defective in NER. Results : For normal human fibroblasts the radioprotective effect of BBI was clearly found by using a delayed plating procedure. The radioprotective effect was found to be unrelated to an altered induction or repair of radiation-induced DNA dsb. Pre-treatment with BBI did not affect cell killing after exposure to bleomycin or MNNG, but resulted in a significant protection of cells exposed to cisplatin or UVB. These results indicate that pre-treatment with BBI did not alter recombination repair or BER, but was able to modify NER. The latter finding was supported by the observation made for XP-cells, where pre-treatment with BBI failed to result in radioprotection after exposure to ionizing radiation. Conclusions : On the basis of these data it is proposed that the radioprotective effect of BBI is the result of an improved nucleotide excision repair mechanism.</description><subject>Biological and medical sciences</subject><subject>Bleomycin - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - radiation effects</subject><subject>Cells, Cultured</subject><subject>Cisplatin - pharmacology</subject><subject>DNA Repair - drug effects</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Methylnitronitrosoguanidine - pharmacology</subject><subject>Molecular and cellular biology</subject><subject>Molecular genetics</subject><subject>Mutagenesis. Repair</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Radiation-Protective Agents - pharmacology</subject><subject>Space life sciences</subject><subject>Ultraviolet Rays</subject><subject>X-Rays</subject><subject>Xeroderma Pigmentosum - genetics</subject><issn>0955-3002</issn><issn>1362-3095</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtv1TAQhS0EoreFNTvkBWIXasd5OOxoBQWpEpuyjibO-MbFsS-20we_ix-IL7mIh1Rv_JjvHI3nEPKCszecSXbKuroWLC8upGz5I7LhoikLkd8fk82-ms-sPCLHMV5nrGRCPiVHnLW8aSqxIT-uJqRn_nYGV5yZ8JXugk8IEalxkxlM8oGim8ApjFRZ7_wWnVFUobU0LuHG3IClXlPjnflu3JYGGA2kfC1SQEg4Urcoiz6ZESneKRNzjQbcgQmF8vMOE7r0yzDSYUnU-bQ3vMPgRwwz0J3ZzhnxcZlX7Bl5osFGfH7YT8iXD--vzj8Wl58vPp2_uyxUVYpUSKzGoePt0MlawSC07BqBY9c2utSNgKoW9dCAbgBQCMlqXdZtVnQt0wyhEifk9eqbh_JtwZj62cR9B-DQL7FvWdeWjeQZPF1BFXyMAXW_C2aGcN9z1u-D6v8LKiteHqyXYcbxL35NJgOvDgBEBVaHHIGJf7hSZiuWsbcrZpz2eVi3PtixT3BvffitEQ830f0jnhBsmhQE7K_9Elye7YMf-AkQ6MRS</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>DITTMANN, K. H</creator><creator>DIKOMEY, E</creator><creator>MAYER, C</creator><creator>RODEMANN, H. P</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells</title><author>DITTMANN, K. H ; DIKOMEY, E ; MAYER, C ; RODEMANN, H. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-8e4db917b985cab3f8963ed976f2f63a4535b6af6aae33805f257db9970f0ea43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Biological and medical sciences</topic><topic>Bleomycin - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - radiation effects</topic><topic>Cells, Cultured</topic><topic>Cisplatin - pharmacology</topic><topic>DNA Repair - drug effects</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Methylnitronitrosoguanidine - pharmacology</topic><topic>Molecular and cellular biology</topic><topic>Molecular genetics</topic><topic>Mutagenesis. Repair</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Radiation-Protective Agents - pharmacology</topic><topic>Space life sciences</topic><topic>Ultraviolet Rays</topic><topic>X-Rays</topic><topic>Xeroderma Pigmentosum - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DITTMANN, K. H</creatorcontrib><creatorcontrib>DIKOMEY, E</creatorcontrib><creatorcontrib>MAYER, C</creatorcontrib><creatorcontrib>RODEMANN, H. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of radiation biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DITTMANN, K. H</au><au>DIKOMEY, E</au><au>MAYER, C</au><au>RODEMANN, H. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells</atitle><jtitle>International journal of radiation biology</jtitle><addtitle>Int J Radiat Biol</addtitle><date>2000</date><risdate>2000</risdate><volume>76</volume><issue>2</issue><spage>223</spage><epage>229</epage><pages>223-229</pages><issn>0955-3002</issn><eissn>1362-3095</eissn><abstract>Purpose : The radioprotective effect of the Bowman-Birk protease inhibitor (BBI) was previously shown to result from a TP53 dependent mechanism. Whether this effect involves specific DNA repair mechansims is now tested. Material and methods : Normal human fibroblasts were pre-treated with BBI before exposure to X-rays, UVB or to chemical agents (bleomycin, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cisplatin). These agents were chosen because of their ability to induce different spectra of DNA damage. The radiometric agent bleomycin primarily induces double-strand breaks (dsb), which are repaired by recombination; MNNG results in alkylated bases which are repaired by base excision repair (BER); cisplatin results in DNA-crosslinks which are repaired mainly by nucleotide excision repair (NER); and finally UVB generates thymine dimers and thymine-cytosine-6-4 products which are also repaired by NER. Cell survival was analysed by colony formation assay and DNA dsb by constant field gel electrophoresis. The combined effect of BBI and X-rays was also tested for XP-fibroblasts, which are defective in NER. Results : For normal human fibroblasts the radioprotective effect of BBI was clearly found by using a delayed plating procedure. The radioprotective effect was found to be unrelated to an altered induction or repair of radiation-induced DNA dsb. Pre-treatment with BBI did not affect cell killing after exposure to bleomycin or MNNG, but resulted in a significant protection of cells exposed to cisplatin or UVB. These results indicate that pre-treatment with BBI did not alter recombination repair or BER, but was able to modify NER. The latter finding was supported by the observation made for XP-cells, where pre-treatment with BBI failed to result in radioprotection after exposure to ionizing radiation. Conclusions : On the basis of these data it is proposed that the radioprotective effect of BBI is the result of an improved nucleotide excision repair mechanism.</abstract><cop>London</cop><pub>Informa UK Ltd</pub><pmid>10716643</pmid><doi>10.1080/095530000138871</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0955-3002 |
ispartof | International journal of radiation biology, 2000, Vol.76 (2), p.223-229 |
issn | 0955-3002 1362-3095 |
language | eng |
recordid | cdi_informahealthcare_journals_10_1080_095530000138871 |
source | Taylor & Francis; MEDLINE; Taylor & Francis Medical Library - CRKN |
subjects | Biological and medical sciences Bleomycin - pharmacology Cell Survival - drug effects Cell Survival - radiation effects Cells, Cultured Cisplatin - pharmacology DNA Repair - drug effects Fundamental and applied biological sciences. Psychology Humans Methylnitronitrosoguanidine - pharmacology Molecular and cellular biology Molecular genetics Mutagenesis. Repair Protease Inhibitors - pharmacology Radiation-Protective Agents - pharmacology Space life sciences Ultraviolet Rays X-Rays Xeroderma Pigmentosum - genetics |
title | The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A26%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Bowman-Birk%20protease%20inhibitor%20enhances%20clonogenic%20cell%20survival%20of%20ionizing%20radiation-treated%20nucleotide%20excision%20repair-competent%20cells%20but%20not%20of%20xeroderma%20pigmentosum%20cells&rft.jtitle=International%20journal%20of%20radiation%20biology&rft.au=DITTMANN,%20K.%20H&rft.date=2000&rft.volume=76&rft.issue=2&rft.spage=223&rft.epage=229&rft.pages=223-229&rft.issn=0955-3002&rft.eissn=1362-3095&rft_id=info:doi/10.1080/095530000138871&rft_dat=%3Cproquest_infor%3E70972681%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70972681&rft_id=info:pmid/10716643&rfr_iscdi=true |